Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion
- PMID: 28798125
- PMCID: PMC5642957
- DOI: 10.1126/science.aam9949
Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion
Abstract
Perturbation of the gut-associated microbial community may underlie many human illnesses, but the mechanisms that maintain homeostasis are poorly understood. We found that the depletion of butyrate-producing microbes by antibiotic treatment reduced epithelial signaling through the intracellular butyrate sensor peroxisome proliferator-activated receptor γ (PPAR-γ). Nitrate levels increased in the colonic lumen because epithelial expression of Nos2, the gene encoding inducible nitric oxide synthase, was elevated in the absence of PPAR-γ signaling. Microbiota-induced PPAR-γ signaling also limits the luminal bioavailability of oxygen by driving the energy metabolism of colonic epithelial cells (colonocytes) toward β-oxidation. Therefore, microbiota-activated PPAR-γ signaling is a homeostatic pathway that prevents a dysbiotic expansion of potentially pathogenic Escherichia and Salmonella by reducing the bioavailability of respiratory electron acceptors to Enterobacteriaceae in the lumen of the colon.
Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Figures




Comment in
-
Gut cell metabolism shapes the microbiome.Science. 2017 Aug 11;357(6351):548-549. doi: 10.1126/science.aao2202. Science. 2017. PMID: 28798116 No abstract available.
-
Microbiome: The microbiota maintains oxygen balance in the gut.Nat Rev Microbiol. 2017 Oct;15(10):574-575. doi: 10.1038/nrmicro.2017.112. Epub 2017 Sep 4. Nat Rev Microbiol. 2017. PMID: 28867820 No abstract available.
Similar articles
-
5-Aminosalicylic Acid Ameliorates Colitis and Checks Dysbiotic Escherichia coli Expansion by Activating PPAR-γ Signaling in the Intestinal Epithelium.mBio. 2021 Jan 19;12(1):e03227-20. doi: 10.1128/mBio.03227-20. mBio. 2021. PMID: 33468700 Free PMC article.
-
Gegen Qinlian decoction ameliorates murine colitis by inhibiting the expansion of Enterobacteriaceae through activating PPAR-γ signaling.Biomed Pharmacother. 2022 Oct;154:113571. doi: 10.1016/j.biopha.2022.113571. Epub 2022 Aug 22. Biomed Pharmacother. 2022. PMID: 36007273
-
Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis.ISME J. 2017 Jan;11(1):15-30. doi: 10.1038/ismej.2016.114. Epub 2016 Sep 20. ISME J. 2017. PMID: 27648810 Free PMC article.
-
Gut Epithelial Metabolism as a Key Driver of Intestinal Dysbiosis Associated with Noncommunicable Diseases.Infect Immun. 2020 Jun 22;88(7):e00939-19. doi: 10.1128/IAI.00939-19. Print 2020 Jun 22. Infect Immun. 2020. PMID: 32122941 Free PMC article. Review.
-
Oxygen as a driver of gut dysbiosis.Free Radic Biol Med. 2017 Apr;105:93-101. doi: 10.1016/j.freeradbiomed.2016.09.022. Epub 2016 Sep 24. Free Radic Biol Med. 2017. PMID: 27677568 Review.
Cited by
-
The Importance of Nutritional Aspects in the Assessment of Inflammation and Intestinal Barrier in Patients with Inflammatory Bowel Disease.Nutrients. 2022 Nov 2;14(21):4622. doi: 10.3390/nu14214622. Nutrients. 2022. PMID: 36364889 Free PMC article.
-
The gut microbiome regulates the clinical efficacy of sulfasalazine therapy for IBD-associated spondyloarthritis.Cell Rep Med. 2024 Mar 19;5(3):101431. doi: 10.1016/j.xcrm.2024.101431. Epub 2024 Feb 19. Cell Rep Med. 2024. PMID: 38378002 Free PMC article.
-
How bile acids and the microbiota interact to shape host immunity.Nat Rev Immunol. 2024 Nov;24(11):798-809. doi: 10.1038/s41577-024-01057-x. Epub 2024 Jul 15. Nat Rev Immunol. 2024. PMID: 39009868 Review.
-
Host circadian behaviors exert only weak selective pressure on the gut microbiome under stable conditions but are critical for recovery from antibiotic treatment.PLoS Biol. 2022 Nov 9;20(11):e3001865. doi: 10.1371/journal.pbio.3001865. eCollection 2022 Nov. PLoS Biol. 2022. PMID: 36350921 Free PMC article.
-
Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease.Foods. 2022 Sep 5;11(17):2703. doi: 10.3390/foods11172703. Foods. 2022. PMID: 36076888 Free PMC article. Review.
References
-
- Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33:496–503. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R56 AI112949/AI/NIAID NIH HHS/United States
- T32 AI060555/AI/NIAID NIH HHS/United States
- R21 AI114922/AI/NIAID NIH HHS/United States
- F31 AI112241/AI/NIAID NIH HHS/United States
- RC1 DK087307/DK/NIDDK NIH HHS/United States
- R21 AI112258/AI/NIAID NIH HHS/United States
- R01 AI096528/AI/NIAID NIH HHS/United States
- UL1 TR001860/TR/NCATS NIH HHS/United States
- R01 AI112949/AI/NIAID NIH HHS/United States
- R25 GM086262/GM/NIGMS NIH HHS/United States
- R01 AI109799/AI/NIAID NIH HHS/United States
- R01 AI112445/AI/NIAID NIH HHS/United States
- TL1 TR001861/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases